Cole Hugh M

CIK 00016046463 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001604646

Recent Transactions

50 trades

Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−16,666→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−26,550→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−14,100→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−14,100→ 0 total
Disposition to Issuer
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2026-01-23−8,333→ 0 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2025-06-11+26,550→ 26,550 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2024-06-05+14,100→ 14,100 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (Right to Buy)
2023-06-02+14,100→ 14,100 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2023-01-10$1.12/sh−9,182→ 110,082 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2023-01-09$1.10/sh−7,452→ 119,264 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2022-08-01+40,000→ 40,000 total
Award
Jounce Therapeutics, Inc.
Common Stock
2022-08-01+20,000→ 126,716 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2022-06-09+8,333→ 8,333 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2022-06-09+8,333→ 8,333 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-01+85,000→ 85,000 total
Award
Jounce Therapeutics, Inc.
Common Stock
2022-02-01+42,500→ 106,716 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-01+85,000→ 85,000 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2022-01-10$6.65/sh−6,205→ 64,216 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2022-01-07$7.30/sh−3,468→ 70,421 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2021-06-02+100,000→ 100,000 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2021-02-01$11.89/sh+53,400→ 53,400 total
Award
Jounce Therapeutics, Inc.
Common Stock
2021-02-01+26,700→ 73,889 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-22−5,000→ 39,500 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Common Stock
2021-01-22$4.40/sh+5,000→ 60,189 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2021-01-22$11.95/sh−18,000→ 47,189 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Common Stock
2021-01-22$6.55/sh+5,000→ 65,189 total
Exercise/Conversion
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-22−5,000→ 55,000 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2021-01-08$7.00/sh−3,340→ 55,189 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2021-01-07$6.76/sh−2,879→ 58,529 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2020-08-18$4.71/sh−744→ 61,408 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2020-08-17$4.86/sh−454→ 62,152 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2020-08-14$4.64/sh−984→ 62,606 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2020-06-11+7,500→ 7,500 total
Award
Jounce Therapeutics, Inc.
Common Stock
2020-02-03+60,000→ 60,000 total
Award
Jounce Therapeutics, Inc.
Common Stock
2020-02-03+30,000→ 63,590 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2020-01-07$7.78/sh−2,624→ 33,590 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2019-08-16$3.92/sh−1,018→ 36,214 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2019-08-15$4.00/sh−648→ 37,232 total
Sale
Jounce Therapeutics, Inc.
Common Stock
2019-08-14$4.10/sh−670→ 37,880 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2019-07-26+15,000→ 15,000 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2019-02-01+44,500→ 44,500 total
Award
Jounce Therapeutics, Inc.
Common Stock
2019-02-01+22,250→ 38,550 total
Award
Jounce Therapeutics, Inc.
Common Stock
2018-08-13+14,400→ 16,300 total
Purchase
Jounce Therapeutics, Inc.
Common Stock
2018-06-15$7.84/sh+1,900→ 1,900 total
Award
Jounce Therapeutics, Inc.
Stock Option (Right to Buy)
2018-02-01+70,500→ 70,500 total
Disposition to Issuer
ARIAD PHARMACEUTICALS INC
Common Stock
2017-02-16−42,834→ 0 total
Disposition to Issuer
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
2017-02-16−100,000→ 0 total
Disposition to Issuer
ARIAD PHARMACEUTICALS INC
Restricted Stock Units
2017-02-16−9,788→ 0 total
Disposition to Issuer
ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
2017-02-16−78,000→ 0 total
Disposition to Issuer
ARIAD PHARMACEUTICALS INC
Restricted Stock Units
2017-02-16−64,733→ 0 total

Companies

Recent Filings

Address

C/O ASTRIA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 10TH FLOOR

BOSTON, MA, 02210

View on SEC.gov